These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9634473)

  • 1. The influence of exogenous peptide on beta2-microglobulin exchange in the HLA complex: analysis in real-time.
    Morgan CL; Ruprai AK; Solache A; Lowdell M; Price CP; Cohen SB; Parham P; Madrigal JA; Newman DJ
    Immunogenetics; 1998 Jul; 48(2):98-107. PubMed ID: 9634473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD8 stabilizes the HLA class I molecule by promoting beta2M exchange: analysis in real-time.
    Morgan CL; Price CP; Cohen SB; Madrigal JA; Newman DJ
    Hum Immunol; 1999 May; 60(5):442-9. PubMed ID: 10447404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-conformed beta2m-free class I heavy chains are intermediates in generation of soluble HLA by the membrane-bound metalloproteinase.
    Demaria S; DeVito-Haynes LD; Salter RD; Burlingham WJ; Bushkin Y
    Hum Immunol; 1999 Dec; 60(12):1216-26. PubMed ID: 10626735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assembly and dissociation of human leukocyte antigen (HLA)-A2 studied by real-time fluorescence resonance energy transfer.
    Gakamsky DM; Davis DM; Strominger JL; Pecht I
    Biochemistry; 2000 Sep; 39(36):11163-9. PubMed ID: 10998256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide binding to HLA-A2 and HLA-B27 isolated from Escherichia coli. Reconstitution of HLA-A2 and HLA-B27 heavy chain/beta 2-microglobulin complexes requires specific peptides.
    Parker KC; Carreno BM; Sestak L; Utz U; Biddison WE; Coligan JE
    J Biol Chem; 1992 Mar; 267(8):5451-9. PubMed ID: 1544922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of human beta2-microglobulin on major histocompatibility complex I peptide loading and the engineering of a high affinity variant. Implications for peptide-based vaccines.
    Shields MJ; Kubota R; Hodgson W; Jacobson S; Biddison WE; Ribaudo RK
    J Biol Chem; 1998 Oct; 273(43):28010-8. PubMed ID: 9774416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified human beta 2-microglobulin (desLys(58)) displays decreased affinity for the heavy chain of MHC class I and induces nitric oxide production and apoptosis.
    Wang M; Harhaji L; Lamberth K; Harndahl M; Buus S; Heegaard NH; Claesson MH; Nissen MH
    Scand J Immunol; 2009 Mar; 69(3):203-12. PubMed ID: 19281532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro study of the dynamic features of the major histocompatibility complex class I complex relevant to its role as a versatile peptide-receptive molecule.
    Hörig H; Papadopoulos NJ; Vegh Z; Palmieri E; Angeletti RH; Nathenson SG
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13826-31. PubMed ID: 9391112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide ligand structure influences the exchange of beta2-microglobulin by cell surface Kb.
    Cook JR; Myers NB; Hansen TH
    Mol Immunol; 1998 Oct; 35(14-15):929-34. PubMed ID: 9881688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An allosteric mechanism controls antigen presentation by the H-2K(b) complex.
    Gakamsky DM; Boyd LF; Margulies DH; Davis DM; Strominger JL; Pecht I
    Biochemistry; 1999 Sep; 38(37):12165-73. PubMed ID: 10508421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain.
    Carmon L; El-Shami KM; Paz A; Pascolo S; Tzehoval E; Tirosh B; Koren R; Feldman M; Fridkin M; Lemonnier FA; Eisenbach L
    Int J Cancer; 2000 Feb; 85(3):391-7. PubMed ID: 10652432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional characterization of peptide-beta2m fused HLA-A2/MART1(27-35) complexes.
    Shen C; Chang CC; Zhang J; Guo W; Xia L; Meng F; Xie W
    Biochem Biophys Res Commun; 2006 Mar; 342(1):57-65. PubMed ID: 16472765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive peptide ligand exchange by surface class I major histocompatibility complex molecules independent of exogenous beta 2-microglobulin.
    Smith JD; Lie WR; Gorka J; Myers NB; Hansen TH
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7767-71. PubMed ID: 1323851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay.
    Harndahl M; Rasmussen M; Roder G; Buus S
    J Immunol Methods; 2011 Nov; 374(1-2):5-12. PubMed ID: 21044632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay.
    Stuber G; Leder GH; Storkus WT; Lotze MT; Modrow S; Székely L; Wolf H; Klein E; Kärre K; Klein G
    Eur J Immunol; 1994 Mar; 24(3):765-8. PubMed ID: 8125143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice.
    Pascolo S; Bervas N; Ure JM; Smith AG; Lemonnier FA; Pérarnau B
    J Exp Med; 1997 Jun; 185(12):2043-51. PubMed ID: 9182675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased efficiency of folding and peptide loading of mutant MHC class I molecules.
    Beissbarth T; Sun J; Kavathas PB; Ortmann B
    Eur J Immunol; 2000 Apr; 30(4):1203-13. PubMed ID: 10760810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of peptides that bind to the HLA-A2.1 molecule by molecular modelling.
    Lim JS; Kim S; Lee HG; Lee KY; Kwon TJ; Kim K
    Mol Immunol; 1996 Feb; 33(2):221-30. PubMed ID: 8649443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization.
    Buchli R; VanGundy RS; Hickman-Miller HD; Giberson CF; Bardet W; Hildebrand WH
    Biochemistry; 2004 Nov; 43(46):14852-63. PubMed ID: 15544356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the stability of class I major histocompatibility complex (MHC) molecules on the surface of human cells.
    Edidin M; Achilles S; Zeff R; Wei T
    Immunogenetics; 1997; 46(1):41-5. PubMed ID: 9148787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.